United Therapeutics to develop, sell Arena Pharma's hypertension treatment
Reuters India -

United Therapeutics Corp on Thursday signed a deal potentially worth up to $1.2 billion for the rights to develop and sell Arena Pharmaceuticals Inc's pulmonary arterial hypertension treatment(PAH).

Read this story at

Loading...

Related Articles